SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-015067
Filing Date
2016-11-14
Accepted
2016-11-15 13:51:27
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1022461
2 ex31-1.htm EX-31.1 11720
3 ex31-2.htm EX-31.2 11654
4 ex32-1.htm EX-32.1 8878
  Complete submission text file 0001493152-16-015067.txt   3576951

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE imun-20160930.xml EX-101.INS 518983
6 XBRL SCHEMA FILE imun-20160930.xsd EX-101.SCH 46812
7 XBRL CALCULATION FILE imun-20160930_cal.xml EX-101.CAL 41475
8 XBRL DEFINITION FILE imun-20160930_def.xml EX-101.DEF 123567
9 XBRL LABEL FILE imun-20160930_lab.xml EX-101.LAB 285945
10 XBRL PRESENTATION FILE imun-20160930_pre.xml EX-101.PRE 198726
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 161999028
SIC: 2834 Pharmaceutical Preparations